iRhythm Technologies, Inc. (IRTC)

Market Cap	4.66B
Revenue (ttm)	618.59M
Net Income (ttm)	-98.32M
Shares Out	31.93M
EPS (ttm)	-3.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	458,006
Open	153.01
Previous Close	153.96
Day's Range	145.64 - 153.16
52-Week Range	55.92 - 157.13
Beta	1.41
Analysts	Strong Buy
Price Target	138.60 (-5.0%)
Earnings Date	Jul 31, 2025

About IRTC

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor t...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC
• Website: https://www.irhythmtech.com

Financial Performance

In 2024, iRhythm Technologies's revenue was $591.84 million, an increase of 20.13% compared to the previous year's $492.68 million. Losses were -$113.29 million, -8.20% less than in 2023.

Analyst Summary

According to 10 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price target is $138.6, which is a decrease of -5.00% from the latest price.

Price Target

$138.6

(-5.00% downside)

Analyst Consensus: Strong Buy